Clinical trial
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
NCT00484107 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00484107 |
|---|---|
| Title | Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women |
| Official title | A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Postmenopause |
| Intervention type | Drug |
| Interventions | Conjugated Estrogen Cream (Premarin®) |
| Enrollment | 200 |
| Start date | Sep 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Jun 8, 2007 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: